PATENT CLAIM ANALYSIS

Application Number: 15907672
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The present invention concerns to recombinant influenza viruses and modified Vaccinia Ankara viruses (MVA), and to a process for construction of recombinant influenza viruses and modified vaccinia Ankara viruses (MVA) with genes that encode for the  T. gondii  parasite SAGI (MVA) and SAG2 (MVA and influenza) proteins, by means of a homologous recombination technique between two transfer vectors (for construction of MVA virus) and reverse genetics (for construction of influenza virus). Additionally, the present invention describes a vaccine composition using recombinant influenza viruses and modified vaccinia Ankara viruses (MVA), or recombinant adenoviruses and modified vaccinia Ankara viruses (MVA), for immunization against infections caused by the  T. gondii  parasite.

Claim (Index 3):
A process of construction of recombinant influenza viruses of any subtype carrying a viral segment that became bicistronic by duplication of a 3\u2032 non-encoding region and of nucleotides of a 5\u2032 encoding region, carrying an antigen of a  Toxoplasma gondii  protozoa parasite ( T. gondii ), comprising the following steps:\n (a) cloning of a  T. gondii  gene in a transfer plasmid carrying a bicistronic segment of the influenza virus; \n (b) co-transfection of the transfer plasmid of the bicistronic segment carrying an encoding sequence of the  T. gondii  antigen, transfer plasmids of remaining influenza virus segments, and plasmids encoding influenza virus replication proteins; \n (c) generation of the recombinant influenza viruses by reverse genetics; and \n (d) cloning and amplification of the recombinant influenza viruses.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 2.29825
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12808028', '10833744', '10833439', '15512820', '11574285']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6948241668764776
- 35 USC 102 Novelty (BERT): 0.6668143117657128
- Combined Prediction Score: 0.6920231813654012
- Mean Citation Score: 426.785624
- Max Citation Score: 733.7252
- Similarity Product: 607.3795833941937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test